Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MME | P08473 | 2/20 | 0.37 |
| ▸ | ACE | P12821 | 2/20 | 0.37 |
| ▸ | CPA1 | P15085 | 2/20 | 0.37 |
| ▸ | ACE2 | Q9BYF1 | 2/20 | 0.37 |
| ▸ | MMP1 | P03956 | 1/20 | 0.33 |
| ▸ | MMP2 | P08253 | 1/20 | 0.33 |
| ▸ | MMP3 | P08254 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
| ▸ | PKM | P14618 | 1/20 | 0.31 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1659488 | 1.00 | MME (0.37) | MMEACECPA1ACE2MMP1 | |
| SCHEMBL4957734 | 0.76 | ALDH1A1 (0.36) | MMEACECPA1ACE2MMP1 | |
| SCHEMBL1657594 | 0.76 | ALDH1A1 (0.36) | MMEACECPA1ACE2MMP1 | |
| SCHEMBL1657591 | 0.76 | ALDH1A1 (0.36) | MMEACECPA1ACE2MMP1 | |
| SCHEMBL22306273 | 0.75 | MME (0.37) | MMEACECPA1ACE2ALDH1A1 | |
| SCHEMBL7081089 | 0.74 | — | — | |
| SCHEMBL26292989 | 0.74 | — | — | |
| SCHEMBL26292991 | 0.74 | — | — | |
| SCHEMBL20444166 | 0.72 | MME (0.35) | MMEACECPA1ACE2ALDH1A1 | |
| SCHEMBL597622 | 0.72 | ALDH1A1 (0.53) | MMEACECPA1ACE2ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20110297820-A1 | PSEUDACYCLIN AND METHOD OF INDICATION OF A FUNGUS PSEUDALLESCHERIA BOYDII | INSTITUTE OF MICROBIOLOGY AS CR, V.V.I. (CZ) | 2011-12-08 | — | — | US | disclosed |
| EP-2303915-A2 | PSEUDACYCLIN AND METHOD OF INDICATION OF A FUNGUS PSEUDALLESCHERIA BOYDII | Institute Of Microbiology AS CR, v.v.i. (CZ) | 2011-04-06 | — | — | EP | disclosed |
| WO-2009149675-A2 | PSEUDACYCLIN AND METHOD OF INDICATION OF A FUNGUS PSEUDALLESCHERIA BOYDII | INSTITUTE OF MICROBIOLOGY AS CR, V.V.I. (CZ) | 2009-12-17 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110297820-A1 | PSEUDACYCLIN AND METHOD OF INDICATION OF A FUNGUS PSEUDALLESCHERIA BOYDII | PPIA, PPIG, PPID | MME 2184/4885ACE 2399/4885CPA1 97/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.